c
x
chart
exchange
Terminal
Flow
Screener
Markets
Trends
Premium
Alerts
EST
UTC-5 New York
Blue Chip
Log in
Sign up
Janux Therapeutics (JANX) Reports Promising Phase 1 Trial Results, Stock Dips 25%
GuruFocus | Nov 9, 2026 3:26 PM EST
Related Stocks: JANX ,
Read original article